These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 464575)

  • 1. Influence of probenecid on serum levels and urinary excretion of cinoxacin.
    Rodriguez N; Madsen PO; Welling PG
    Antimicrob Agents Chemother; 1979 Mar; 15(3):465-9. PubMed ID: 464575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cinoxacin: pharmacokinetics and the effect of probenecid.
    Israel KS; Black HR; Nelson RL; Brunson MK; Nash JF; Brier GL; Wolney JD
    J Clin Pharmacol; 1978 Oct; 18(10):491-9. PubMed ID: 711932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinoxacin in female mongrel dogs: effect of urine pH on urinary drug excretion and correlation of in vitro characteristics of oral dosage forms with bioavailability.
    Quay JF; Childers RF; Johnson DW; Nash JF; Stucky JF
    J Pharm Sci; 1979 Feb; 68(2):227-32. PubMed ID: 34019
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacology of cinoxacin in humans.
    Black HR; Israel KS; Wolen RL; Brier GL; Obermeyer BD; Ziege EA; Wolny JD
    Antimicrob Agents Chemother; 1979 Feb; 15(2):165-70. PubMed ID: 426511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cinoxacin concentrations in plasma, urine and prostatic tissue after oral administration to man.
    Burt RA; Morgan T; Payne JP; Bonner RM
    Br J Urol; 1977 Apr; 49(2):147-52. PubMed ID: 858034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosoxacin and cinoxacin distribution in prostate, vagina, and female urethra. An experimental study in dogs.
    Maigaard S; Frimodt-Möller N; Hoyme U; Madsen PO
    Invest Urol; 1979 Sep; 17(2):149-52. PubMed ID: 468515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cinoxacin: pharmacokinetics and tolerance in patients with normal and impaired renal function.
    Maigaard S; Frimodt-Möller N; Welling PG; Madsen PO
    Antimicrob Agents Chemother; 1979 Sep; 16(3):411-6. PubMed ID: 507797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of cinoxacin in urinary tract infections.
    Panwalker AP; Giamarellou H; Jackson GG
    Antimicrob Agents Chemother; 1976 Mar; 9(3):502-5. PubMed ID: 1259405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of urinary pH on the pharmacokinetics of cinoxacin in humans and on antibacterial activity in vitro.
    Barbhaiya RH; Gerber AU; Craig WA; Welling PG
    Antimicrob Agents Chemother; 1982 Mar; 21(3):472-80. PubMed ID: 7103450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetic profiles of cinoxacin and pipemidic acid in humans.
    Brogard JM; Comte F; Lavillaureix J
    Eur J Drug Metab Pharmacokinet; 1983; 8(3):251-9. PubMed ID: 6653617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cinoxacin: mechanism of action, spectrum of activity, pharmacokinetics, adverse reactions, and therapeutic indications.
    Scavone JM; Gleckman RA; Fraser DG
    Pharmacotherapy; 1982; 2(5):266-72. PubMed ID: 6763208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-dependent elimination of cinoxacin in rats.
    Koike M; Norikura R; Mizojiri K; Sugeno K
    J Pharm Sci; 1984 Dec; 73(12):1697-700. PubMed ID: 6527237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cinoxacin in urinary tract infections. Theoretical and practical considerations.
    Madsen PO; Frimodt-Møller N; Maigaard S; Nielsen OS; Rodriguez N; Welling PG
    Urology; 1981 May; 17(5):496-9. PubMed ID: 7233671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cinoxacin in patients with renal failure.
    Szwed JJ; Brannon DE; Sloan RS; Luft FC
    J Antimicrob Chemother; 1978 Sep; 4(5):451-4. PubMed ID: 690045
    [No Abstract]   [Full Text] [Related]  

  • 15. Probenecid: an unexplained effect on cephalosporin pharmacology.
    Welling PG; Dean S; Selen A; Kendall MJ; Wise R
    Br J Clin Pharmacol; 1979 Nov; 8(5):491-5. PubMed ID: 508557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal responses and pharmacokinetics of piretanide in humans: effect of route of administration, state of hydration and probenecid pretreatment.
    Noormohamed FH; McNabb WR; Dixey JJ; Lant AF
    J Pharmacol Exp Ther; 1990 Sep; 254(3):992-9. PubMed ID: 2395126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of intravenously administered cefmetazole and cefoxitin and effects of probenecid on cefmetazole elimination.
    Ko H; Cathcart KS; Griffith DL; Peters GR; Adams WJ
    Antimicrob Agents Chemother; 1989 Mar; 33(3):356-61. PubMed ID: 2729930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of probenecid and spironolactone on furosemide kinetics and dynamics in man.
    Homeida M; Roberts C; Branch RA
    Clin Pharmacol Ther; 1977 Oct; 22(4):402-9. PubMed ID: 902453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of dose doubling with probenecid for sustaining serum cefuroxime levels.
    Garton AM; Rennie RP; Gilpin J; Marrelli M; Shafran SD
    J Antimicrob Chemother; 1997 Dec; 40(6):903-6. PubMed ID: 9462447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of orally administered probenecid on the pharmacokinetics of cefoxitin.
    Vlasses PH; Holbrook AM; Schrogie JJ; Rogers JD; Ferguson RK; Abrams WB
    Antimicrob Agents Chemother; 1980 May; 17(5):847-55. PubMed ID: 7396472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.